• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Device Problem Malposition of Device (2616)
Patient Problem Hematoma (1884)
Event Date 04/09/2015
Event Type  Injury  
Event Description
It was reported in a publication that 77 patients were enrolled in a prospective study.Use of bmp-2 was determined on an individual basis.Demographic and operative characteristics were recorded.Fusion rates were determined by a blinded reviewer and several functional outcomes were collected including visual analog pain scores (vas), oswestry disability index (odi), sciatica bothersome index (sbi), and short form---36 (sf---36) scores.Outcomes data was collected at each follow up visit.Of the 77 patients enrolled, 29 received bmp and 48 did not.Increased use of iliac crest autograft (41.7% vs 6.9%, p =.001) and blood loss (1035.2 vs 608.6 cc, p =.042) were noted in the control group.There were significant improvements in postoperative leg pain as measured by vas leg and sbi scores for the entire cohort without clinically significant differences between the bmp and control groups.Significant improvements were also found in vas back, odi, and sf-36 scores.Two reoperations occurred in each group for misplaced hardware, hematoma evacuation, and revision decompression.
 
Manufacturer Narrative
Article citation: sebastian et al.Prospective evaluation of radiculitis following bmp-2 use for interbody arthrodesis in spine surgery.8th annual lumbar spine research society (lsrs) meeting 2015, 09-10 april chicago, usa.Implanted date: may 2009 ¿ september 2013.(b)(6).(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Products from multiple manufacturers were implanted during the procedure.Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key4795614
MDR Text Key5818258
Report Number1030489-2015-01039
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/28/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/28/2015
Initial Date FDA Received05/26/2015
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-